Issues That Slowed Progress in Assessments of Health-Related Quality of Life in Schizophrenia

  • A. George AwadEmail author
  • Lakshmi N. P. Voruganti


This chapter provides a review of the factors that have been identified to slow further development of the construct of health-related quality of life in schizophrenia. The lack of agreement on a definition has led to a multiplicity of definitions that frequently are not based on clear theoretical and conceptual models. It also led to the development of a wide range of measurement approaches that lack common standard metrics that make it difficult to compare data among various studies. As most of the research efforts have focused mostly on assessment of quality of life and rarely had gone beyond assessment into what to do with assessment data, there has been growing perception about the lack of utility of quality of life assessments in clinical practice. Similarly, the lack of impact on pharmacoeconomics, policy decision-making and resource utilization has further eroded the usefulness of such an important concept. We believe that the concept of quality of life in schizophrenia needs to be reinvigorated by going beyond assessments and into the development of approaches for integration in clinical care plans and also playing a significant role in pharmacoeconomics. As quality of life in schizophrenia is the ultimate for what patients and their physicians, as well as society at large, aspire, it can also serve as an effective tool in outcomes research applicable to health economics, resource allocations and health policy decision-making.


Subjective Quality Computer Adaptive Testing Objective Construct Total PANSS Score Chronic Psychiatric Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Adelen MO, Reeve BP. Applying item response theory (IRT) modeling to questionnaire development, evaluation and refinement. Qual Life Res. 2007;16:5–18.CrossRefGoogle Scholar
  2. Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophr Bull. 1993;19:609–18.CrossRefPubMedGoogle Scholar
  3. Awad AG, Voruganti LN. Antipsychotics, schizophrenia and the issue of quality of life. In: Ritsner M, Awad AG, editors. Quality of life impairment in schizophrenia, mood and anxiety disorders. Dordrecht: Springer; 2007. p. 307–19.CrossRefGoogle Scholar
  4. Awad AG, Voruganti LN. Measurement of quality of life in patients with schizophrenia – an update. Pharmacoeconomics. 2012;30:183–95.CrossRefPubMedGoogle Scholar
  5. Awad AG, Voruganti LN, Heslegrave RJ. The aim of antipsychotic medications: what are they and are they being achieved? CNS Drugs. 1995;19:609–18.Google Scholar
  6. Awad AG, Voruganti LN, Heslegrave RS. Preliminary validation of a conceptual model to assess quality of life in schizophrenia. Qual Life Res. 1997;6:21–6.CrossRefPubMedGoogle Scholar
  7. Bacharach LL. Deinstitutionalization: an analytic review and sociological perspective. Rockville: National Institute of Health; 1976.Google Scholar
  8. Baumstarck K, Boyer L, Boucekine M. Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophr Res. 2013;147:58–67.CrossRefPubMedGoogle Scholar
  9. Becchi A, Rucci P, Placentino A, Veri G, de Girolamo G. Quality of life in patients with schizophrenia – comparison of self-reports and proxy assessments. Soc Psychiatry Psychiatr Epidemiol. 2004;30:397–401.CrossRefGoogle Scholar
  10. Bergner M. The sickness impact profile: development and brief summary of its purpose, uses and administration. Seattle/Washington: University of Washington; 1978.Google Scholar
  11. Calman KC. Quality of life in cancer patients: an hypothesis. J Med Ethics. 1984;10:124–7.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Campbell A. The sense of well-being in america. New York: McGraw-Hill; 1981.Google Scholar
  13. Campbell A, Converse PE, Rogers WC. Subjective measures of well-being. Am Psychol. 1976;31:117–24.CrossRefPubMedGoogle Scholar
  14. Eklund M, Backstrom M. A model of subjective quality of life for outpatients with schizophrenia and other psychoses. Qual Life Res. 2005;14:1157–68.CrossRefPubMedGoogle Scholar
  15. Fitzgerald PB, Williams CL, Cortiling N, Filig SL, Brewer K, Adams A, deCastella AR, Rolfe T, Davey P, Kulkarni J. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand. 2001;103:387–92.CrossRefPubMedGoogle Scholar
  16. Galbraith JK. The affluent society. Boston: Houghton & Mifflin; 1958.Google Scholar
  17. Gill TM, Feinstein AR. Critical appraisal of the quality of quality-of-life measurements. JAMA. 1995;272:619–26.CrossRefGoogle Scholar
  18. Glazer W, Sholomskas D, Williams D, Weissman M. Chronic schizophrenia in the community: are they able to report their social adjustment? Am J Orthopsychiatry. 1982;52:166–71.CrossRefPubMedGoogle Scholar
  19. Gurin G, Verhof J, Feld S. Americans view their mental health. New York: Russel Sage Foundation; 1960.Google Scholar
  20. Hayhurst KP, Massie S, Dunn G, Lewis S, Drake RJ. Validity of subjective versus objective quality of life in people with schizophrenia. BMC Psychiatry. 2014;14:365–9.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Hogan TP, Awad AG, Eastwood RA. A self-rated scale predictive of drug compliance in schizophrenia: reliability and discriminative abilities. Psychol Med. 1983;13:177–83.CrossRefPubMedGoogle Scholar
  22. Khatri N, Romney D, Pelletier G. Validity of self-reports about quality of life among patients with schizophrenia. Psychiatr Serv. 2001;52:534–5.CrossRefPubMedGoogle Scholar
  23. Lehman A. The well-being of chronic mental patients: assessing their quality of life. Arch Gen Psychiatry. 1983;40:369–73.CrossRefPubMedGoogle Scholar
  24. Lehman A, Ward N, Linn L. Chronic mental patients: the quality of life issue. Am J Psychiatry. 1982;139:1271–6.CrossRefPubMedGoogle Scholar
  25. Lehman A, Possidente S, Hawker F. The quality of life of chronic patients in state hospitals and in community residences. Hosp Community Psychiatry. 1986;37:901–7.PubMedGoogle Scholar
  26. Luborsky L, Bachrach H. Factors influencing clinicians’ judgments of mental health: eighteen experiences with the health-sickness rating scale. Arch Gen Psychiatry. 1974;31:292–9.CrossRefPubMedGoogle Scholar
  27. Najman JM, Levine S. Evaluating the impact of medical care and technologies on the quality of life: a review and critique. Soc Sci Med. 1981;15:107–15.Google Scholar
  28. Reininghaus U, McCabe R, Burns T, Croudace T, Priebe S. The validity of subjective quality of life measures in psychotic patients with severe psychopathology and cognitive deficits: an item response model analysis. Qual Life Res. 2012;2012:237–46.CrossRefGoogle Scholar
  29. Ritsner M. The distress/protection vulnerability model of quality of life impairment syndrome. In: Ritsner M, Awad AG, editors. Quality of life impairment in schizophrenia, mood and anxiety disorders. Dodrecht: Springer; 2007. p. 3–20.CrossRefGoogle Scholar
  30. Russo J, Trufillo CA, Wengerson D. The MOS-36 item short form health survey: reliability, validity and preliminary findings in schizophrenic outpatients. Med Care. 1998;36:752–6.CrossRefPubMedGoogle Scholar
  31. Skantz K. Subjective quality of life and standard of living: a 10-year follow-up of outpatients with schizophrenia. Acta Psychiatr Scand. 1998;98:390–8.CrossRefGoogle Scholar
  32. Skantz K, Malm U, Denker SJ. Comparison of quality of life with standard of living in schizophrenic outpatients. Br J Psychiatry. 1992;161:797–801.CrossRefGoogle Scholar
  33. Spaulding W, Hargrave S, Crincan W, Martin T. A microcomputer based laboratory for psychopathology research in rural settings. Behav Res Meth Instrum. 1981;13:616–23.CrossRefGoogle Scholar
  34. Stuart E, Wykes T. Assessment schedules for chronic psychiatric patients. Psychol Med. 1987;17:485–93.CrossRefGoogle Scholar
  35. Voruganti LN, Heselgrave R, Awad AG, Seeman M. Quality of life measurement in schizophrenia: reconciling the question of subjectivity with question of reliability. Psychol Med. 1998;28:165–72.CrossRefPubMedGoogle Scholar
  36. Voruganti LN, Awad AG, Parker G, Forrest C, Usmani Y, Fernando MLD, Senthislal S. Cognition, functioning and quality of life in schizophrenia treatment: results of one year randomized controlled trial of olanzapine and quetiapine. Schizophr Res. 2007;96:146–55.CrossRefPubMedGoogle Scholar
  37. Ware Jr JE. The SF-36 health survey in quality of life and pharmacoeconomics clinical trials. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-raven; 1996. p. 337–45.Google Scholar
  38. Wood S, William JI. Reintegration to normal living as a proxy to quality of life. J Chronic Dis. 1987;40:497–509.Google Scholar
  39. World Health Organization (WHO). The constitution of the World Health Organization. WHO Chron. 1947;1:29–43.Google Scholar
  40. Zissi A, Barry MU, Cochrane RA. A mediational model of quality of life for individuals with severe mental health problems. Psychol Med. 1998;28:1221–30.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Psychiatry, The Institute of Medical ScienceUniversity of TorontoTorontoCanada
  2. 2.Department of PsychiatryOakville-Trafalgar Memorial HospitalOakvilleCanada

Personalised recommendations